Governance

Governance

ILSI Europe is a non-profit organisation. It is governed by three bodies composed of industry and non-industry members. The General Assembly of Members is the ultimate decision-making body. The Board of Directors directs and control the management of ILSI Europe. The Scientific Advisory Committee reviews and endorses the overall scientific programme of ILSI Europe.

General Assembly

The General Assembly of Members provides the programme and financial oversight for all ILSI Europe activities. It is the ultimate decision-making body in which all member companies are represented. The General Assembly elects the members of the Board of Directors.

As of March 2023, ILSI Europe counts with the support of 38 members companies.

 

Board of Directors

The Board of Directors is composed of 10 directors representing ILSI Europe’s member companies and at least an equal or greater number of scientists from academic institutions or governmental bodies in order to ensure a balanced input. Each year, one third of the members retires but is eligible for re-election. Candidates recommended by the Nomination Committee to fill the Board vacancies are elected for a three-year term by the General Assembly. In June 2016, the Board of Directors decided to put a two-year rotation scheme in place for Board leadership positions (both public and private).

The remit of the Board of Directors is to direct and control the management of ILSI Europe, such as:

  • To elect the Board Officers from the members of the Board of Directors;
  • To prepare the annual accounts and to propose the budget of the forthcoming year;
  • To propose amendments to the Charter of Incorporation, changes in the structure of the Institute or the dissolution of the Institute to the General Assembly.

It also directs and controls the scientific activities of ILSI Europe, such as:

  • Approving the scientific content of the programme, following the advice of the Scientific Advisory Committee, ensuring its execution, and reporting back on the progress and status of the programme to the General Assembly;
  • Appointing the members of the Scientific Advisory Committee and proposing the establishment or dissolution of scientific committees to the General Assembly.

Nomination Committee

Every year, one third of the members of the Board of Directors is on rotation. Chaired by the President of ILSI Europe, the Nomination Committee recommends candidates to the General Assembly to fill the vacancies in the Board of Directors based on their expertise, their prestige and their availability for active contribution. The Committee is composed of the President, the Chair of the Board of Directors, the Past President, two industry non-director members, and two non-industry, non-director scientists of international renown nominated by the General Assembly and representing different geographical regions of Europe. The Board of Directors recommends candidates to the General Assembly to fill vacancies in the Nomination Committee.

Scientific Advisory Committee

The Scientific Advisory Committee (SAC) is composed of a maximum of 20 experts with more than 50% coming from the non-industry sector. It is chaired by the President of ILSI Europe and vice-chaired by the Vice-President. The members of the SAC are appointed for a three-year term by the Board of Directors according to their relevant expertise, their prestige and availability for active contribution. SAC members can serve a maximum of two terms.

The tasks of the Scientific Advisory Committee are:

  • To review and endorse the overall scientific programme of ILSI Europe, including the new activities with respect to their scientific validity, coherence within ILSI Europe’s programme, feasibility and urgency of the issues;
  • To monitor the composition of expert groups and task forces (including the appointment of Co-Chairs and scientific advisors) to ensure scientific integrity;
  • To provide scientific guidance to the task forces and expert groups;
  • To identify emerging issues to be dealt with by ILSI Europe;
  • To advise the Board of Directors on scientific matters.

WP DataTables

Corporate Documents